BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruggiero R, Fraenza F, Scavone C, di Mauro G, Piscitelli R, Mascolo A, Ferrajolo C, Rafaniello C, Sportiello L, Rossi F, Capuano A. Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database. Front Pharmacol 2020;11:830. [PMID: 32581796 DOI: 10.3389/fphar.2020.00830] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Casarotto E, Noize P, Létinier L, Salvo F, Pham-Ledard A, Molimard M. Safety profile of drugs for advanced melanoma: A report based on 2008-2018 US Food and Drug Administration Data. Br J Clin Pharmacol 2021;87:2988-95. [PMID: 33294983 DOI: 10.1111/bcp.14693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 di Mauro G, Mascolo A, Gaio M, Rafaniello C, De Angelis A, Berrino L, Paolisso G, Rossi F, Capuano A. The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study. Pharmaceuticals 2022;15:286. [DOI: 10.3390/ph15030286] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mascolo A, di Mauro G, Cappetta D, De Angelis A, Torella D, Urbanek K, Berrino L, Nicoletti GF, Capuano A, Rossi F. Current and future therapeutic perspective in chronic heart failure. Pharmacol Res 2021;175:106035. [PMID: 34915125 DOI: 10.1016/j.phrs.2021.106035] [Reference Citation Analysis]
4 Ruggiero R, Motta G, Massaro G, Rafaniello C, Della Corte A, De Angelis A, Capuano A, Motta G, Rossi F. Pharmacological, Technological, and Digital Innovative Aspects in Rhinology. Front Allergy 2021;2:732909. [DOI: 10.3389/falgy.2021.732909] [Reference Citation Analysis]
5 Mascolo A, Scavone C, Ferrajolo C, Rafaniello C, Danesi R, Del Re M, Russo A, Coscioni E, Rossi F, Alfano R, Capuano A. Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance. Drug Saf 2021;44:957-71. [PMID: 34145536 DOI: 10.1007/s40264-021-01086-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Gargano F, Scavone C, di Mauro G, Corte AD, Zoccoli A, Rossi F, Nicoletti GF, Capuano A. The Safety Profile of General and Local Anaesthetic Agents: Data Collected during 20 Years of Spontaneous Reporting Activities in the Campania Region (Southern Italy). Pharmaceuticals (Basel) 2021;14:1261. [PMID: 34959662 DOI: 10.3390/ph14121261] [Reference Citation Analysis]
7 Wu F, Zhou C, Wu B, Zhang X, Wang K, Wang J, Xiao L, Wang G. Adding Adjuvants to Fluoropyrimidine-based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: An Option Worthy of Serious Consideration. J Cancer 2021;12:417-27. [PMID: 33391438 DOI: 10.7150/jca.48337] [Reference Citation Analysis]